ATE415629T1 - In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion - Google Patents
In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektionInfo
- Publication number
- ATE415629T1 ATE415629T1 AT06809138T AT06809138T ATE415629T1 AT E415629 T1 ATE415629 T1 AT E415629T1 AT 06809138 T AT06809138 T AT 06809138T AT 06809138 T AT06809138 T AT 06809138T AT E415629 T1 ATE415629 T1 AT E415629T1
- Authority
- AT
- Austria
- Prior art keywords
- kit
- diagnostic procedure
- vitro diagnostic
- black mold
- mold infection
- Prior art date
Links
- 238000000338 in vitro Methods 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 102000016938 Catalase Human genes 0.000 abstract 2
- 108010053835 Catalase Proteins 0.000 abstract 2
- 101710087092 Dipeptidyl-peptidase 5 Proteins 0.000 abstract 2
- 101710168595 Probable dipeptidyl-peptidase 5 Proteins 0.000 abstract 2
- 102000006382 Ribonucleases Human genes 0.000 abstract 2
- 108010083644 Ribonucleases Proteins 0.000 abstract 2
- 201000002909 Aspergillosis Diseases 0.000 abstract 1
- 241000228212 Aspergillus Species 0.000 abstract 1
- 208000036641 Aspergillus infections Diseases 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/38—Assays involving biological materials from specific organisms or of a specific nature from fungi from Aspergillus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05291428A EP1739428A1 (en) | 2005-07-01 | 2005-07-01 | In vitro diagnostic method and kit for an aspergillus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415629T1 true ATE415629T1 (de) | 2008-12-15 |
Family
ID=35385774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06809138T ATE415629T1 (de) | 2005-07-01 | 2006-06-30 | In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7888041B2 (enExample) |
| EP (2) | EP1739428A1 (enExample) |
| JP (1) | JP4959697B2 (enExample) |
| AT (1) | ATE415629T1 (enExample) |
| CA (1) | CA2613727C (enExample) |
| DE (1) | DE602006003903D1 (enExample) |
| ES (1) | ES2318799T3 (enExample) |
| WO (1) | WO2007015177A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10585098B2 (en) | 2009-11-23 | 2020-03-10 | The Johns Hopkins University | Optimizing diagnostics for galactofuranose containing antigens |
| WO2011063395A2 (en) * | 2009-11-23 | 2011-05-26 | The Johns Hopkins University | Lateral flow device for diagnosing microbial infections |
| CN102174485B (zh) * | 2011-02-18 | 2013-07-17 | 中国人民解放军南京军区南京总医院 | 一种曲霉免疫优势抗原及用途 |
| WO2012162324A2 (en) * | 2011-05-23 | 2012-11-29 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno | Method of diagnosing and treating an aspergillus species-associated condition |
| US10107822B2 (en) | 2013-12-16 | 2018-10-23 | The Johns Hopkins University | Interferon-gamma release assays for diagnosis of invasive fungal infections |
| CN110954696A (zh) * | 2019-11-27 | 2020-04-03 | 深圳华瑞达生物科技有限公司 | 一种曲霉半乳甘露聚糖聚糖检测试剂盒及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919671D0 (en) * | 1989-08-31 | 1989-10-11 | Bush Boake Allen Ltd | Biotransformation of fatty substrates |
| SE9604815D0 (sv) * | 1996-12-20 | 1996-12-20 | Pharmacia & Upjohn Ab | A metod of diagnosis |
| WO2000039322A1 (en) * | 1998-12-23 | 2000-07-06 | Novozymes A/S | Methods for producing polypeptides in aspergillus mutant cells |
| EP1104768B1 (en) * | 1999-12-02 | 2006-11-29 | Council of Scientific and Industrial Research | Peptide sequences from aspergillus fumigatus for the diagnosis of aspergillosis |
| JP2002223772A (ja) * | 2001-02-01 | 2002-08-13 | Gekkeikan Sake Co Ltd | カタラーゼａ遺伝子 |
-
2005
- 2005-07-01 EP EP05291428A patent/EP1739428A1/en not_active Withdrawn
-
2006
- 2006-06-30 US US11/988,038 patent/US7888041B2/en active Active
- 2006-06-30 DE DE602006003903T patent/DE602006003903D1/de active Active
- 2006-06-30 CA CA2613727A patent/CA2613727C/en active Active
- 2006-06-30 WO PCT/IB2006/003039 patent/WO2007015177A2/en not_active Ceased
- 2006-06-30 ES ES06809138T patent/ES2318799T3/es active Active
- 2006-06-30 EP EP06809138A patent/EP1907853B1/en active Active
- 2006-06-30 JP JP2008520024A patent/JP4959697B2/ja active Active
- 2006-06-30 AT AT06809138T patent/ATE415629T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1739428A1 (en) | 2007-01-03 |
| JP4959697B2 (ja) | 2012-06-27 |
| US20090305312A1 (en) | 2009-12-10 |
| ES2318799T3 (es) | 2009-05-01 |
| JP2009500620A (ja) | 2009-01-08 |
| WO2007015177A8 (en) | 2007-07-19 |
| CA2613727A1 (en) | 2007-02-08 |
| US7888041B2 (en) | 2011-02-15 |
| EP1907853A2 (en) | 2008-04-09 |
| CA2613727C (en) | 2020-07-14 |
| WO2007015177A3 (en) | 2007-04-12 |
| EP1907853B1 (en) | 2008-11-26 |
| DE602006003903D1 (de) | 2009-01-08 |
| WO2007015177A2 (en) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX340547B (es) | Equipos de prueba de diagnostico. | |
| TW200512457A (en) | Method of diagnosing SARS corona virus infection | |
| EP1381864A4 (en) | DETECTION OF CANDIDA | |
| DK1092155T3 (da) | Fremgangsmåde til tidlig diagnose af carcinomer | |
| MA29528B1 (fr) | Agents de fixation | |
| IL188460A0 (en) | Diagnostic methods and compositions for diagnosing and treating influenza | |
| BR0206604A (pt) | Dispositivo de lanceta que tem ação capilar | |
| WO2010009987A3 (en) | Diagnostic antibody assay | |
| WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
| WO2007132120A3 (fr) | Procede et methodes de detection de la maladie d'alzheimer | |
| EP2295979A3 (en) | Protein detection reagents and methods with dyes and dextrins | |
| ATE415629T1 (de) | In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion | |
| WO2006093797A3 (en) | Method and kit for detecting porcine reproductive and respiratory syndrome virus | |
| MY146476A (en) | Method of diagnosing lawsonia intracellularis | |
| FI20012603A0 (fi) | Diagnostinen menetelmä | |
| GB0706558D0 (en) | Diagnostic assay | |
| WO2006067792A3 (en) | Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease | |
| AP2007003884A0 (en) | Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same. | |
| GB2455929A (en) | A method for the identification of human immunodeficiency virus related antibodies in blood | |
| WO2007022086A3 (en) | Antibodies and methods for predicting dental caries | |
| WO2004029216A3 (en) | Diagnosis of invasive mold infection | |
| WO2010053772A3 (en) | Disease-associated antigens and methods of use thereof | |
| WO2010142906A3 (fr) | Antigenes proteiques destines au serodiagnostic des infections a staphylococcus aureus notamment sur protheses osteo-articulaires | |
| WO2006001972A3 (en) | Compositions and methods for the diagnosis of group b streptococcus infection | |
| ATE511646T1 (de) | Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1907853 Country of ref document: EP |